UNIT DOSE
The right dose, at the right place, at the right time.
No waste.
GMS Australia extemporaneously compounds SPECT & PET Radiopharmaceuticals made to order by customers for particular persons.
Unit dose is a complete solution to your radiopharmaceutical needs.
Individual doses are prepared, quality-assured and packaged for each scan.
Doses are delivered on time to departments for administration to patients.
The unit dose service includes the retrieval, decay and disposal of all radioactive waste from delivered doses.
Unit dose also includes free use of GMS's Secure Insert system; a safe reliable method for handling and disposal of radioactive sharps.
Save time and money.
Improved workflow with ready- to-inject doses delivered daily.
Reduced need for in-house compounding of doses that require multiple steps, such as heating.
No need to complete additional QC on compounded ready-to-inject radiopharmaceuticals.
Single point of contact for all of your department's radiopharmacy needs.
Improved utiliisation of staff/resources due to decreased time required for complex compounding.
GMS resources available to assist with troubleshooting and quality control enquiries.
Reliable supply of compounded radiopharmaceuticals, cold reagent kits & raw materials allows more departments to offer a full suite of NM & related studies.
Improved access to a greater range of studies via novel & exclusively licensed tracers - supported by a national radiopharmacy network.
National network of TGA/GMP licensed & regulated radiopharmacies supported by a comprehensive regulatory & quality assurance team.
Stringent, validated quality control procedures in alignment with registered PI recommendations reduces need for in-house QC.
Mitigate quality-related risks using TGA/GMP-licensed and pharmacy-regulated centralised radiopharmacies.
Batch tracked, traceability on all released products.
All activity is measured using equipment regularly calibrated to manufacturer's recommendations.
Patient's can be assured of the quality of the radiopharmaceuticals being injected.
ARTG-registered products used in the production of compounded radiopharmaceuticals.
Patient safety is protected by strict, validated SOPs and industry leading quality assurance measures.
Reduced laboratory workload and associated reduction in staff radiation exposure.
Supply of ready-to-inject radiopharmaceuticals means staff can focus on other departmental tasks.
Reduction in time spent by staff navigating regulatory issues.
Unit dose decreases the need to use an entire cold kit vial for in-house compounding for a single patient.
Radioactive waste can be handled more effectively and efficiently.
Streamlined access to Section 19, SA, orphan, unregulated & other low-demand products.
Department efficiency & patient throughput can be improved by utilising centralised radiopharmacies.
The cost of therapeutic & international isotope orders may be significantly reduced when ordering through CRP's due to efficiencies of scale and consolidated ordering processes.
For Terms & Conditions of Unit Dose availability, please visit our Regulatory and Compliance section.
